Paul Peter Tak
Director, Chief Executive Officer · 1 filing · Latest: Jan 26, 2026
Candel Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CADL | PAUL PETER TAK | — | Mar 18, 2025 | Proposed Sale | $8.83 | 74,106 | $654.4K | — | |
CADL | Tak Paul Peter | — | Jan 15, 2025 | Proposed Sale | $7.84 | 19,970 | $156.6K | — | |
CADL | Tak Paul Peter | — | Jan 8, 2025 | Proposed Sale | $8.35 | 20,811 | $173.8K | — | |
CADL | Tak Paul Peter | — | Nov 29, 2024 | Proposed Sale | $4.95 | 44,433 | $219.9K | — |